FDA approves Wegovy to lower risk for CVD events in patients with obesity
Mar 08, 2024
Agency’s action could widen access to the drug if more insurance companies decide to cover it
Patterns studied for alcohol intake, outcomes in patients with CVD
Jul 29, 2021
Relative to nondrinkers, a J-shaped curve was seen for all-cause mortality, cardiovascular mortality, and cardiovascular events in drinkers with preexisting cardiovasular disease.
Menopausal hormone therapy use beyond 65 years beneficial
Apr 16, 2024
Use of menopausal hormone therapy beyond age 65 years is associated with risk reductions in mortality as well as specific cancers and cardiovascular diseases, according to a study published online April...
Recent rise in disability, years of life lost from CVD due to air pollution
Aug 16, 2023
Age-standardized rates for deaths decreased, but all-age disability-adjusted life years increased.
Comprehensive approach advised for managing cardiovascular risk in type 2 diabetes
Jan 14, 2022
In addition to managing all cardiovascular risk factors, providers must consider social determinants of health.
Spring daylight savings transition tied to increase in cardiovascular events
Mar 14, 2024
The authors, however, say that there is a very low estimated probability that this association is of clinical importance.
Light alcohol intake may not protect against cardiovascular disease
Mar 30, 2022
Heavy consumption was tied to exponential increases of cardiovascular disease risk.
Clinical decision support may cut cardiovascular disease risk
Feb 10, 2022
Decreases were seen for reversible risk in vulnerable patients with high baseline risk.
Statin use low for primary prevention of atherosclerotic CVD
Mar 22, 2023
Statin use was lower in Black and Hispanic versus white adults, including in the highest risk stratum.
Colchicine tied to lower incidence of TJA in coronary artery disease
May 31, 2023
A lower incidence of total knee replacement and total hip replacement was seen with the use of colchicine, 0.5 mg daily.